Cerulean Pharma reported $12.67M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agile Therapeutics AGRX:US 17.06M 775K
Arrowhead Research ARWR:US $ 103.17M 25.41M
Bayer BAYN:GR 9.25B 3.88B
Biocept BIOC:US $ 16.97M 3.17M
Brainstorm Cell Therapeutics BCLI:US $ 5.28M 844K
Cerulean Pharma CERU:US $ 12.67M 3.51M
Immunogen IMGN:US $ 43.44M 873K
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Macrogenics MGNX:US $ 68.65M 2.39M
Merk MRK:US $ 8328M 1460M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Perrigo Ordinary Shares PRGO:US $ 604.4M 502.6M
Pfizer PFE:US $ 16447M 3384M
Seattle Genetics SGEN:US $ 722.02M 243.94M
YTE INCY:US $ 577.58M 12.7M